CHAPEL HILL, N.C., Nov. 6 /PRNewswire/ -- POZEN Inc. (Nasdaq: POZN), a
pharmaceutical development company with a portfolio of migraine products,
today announced it plans to conduct a conference call following the release of
financial results for the third quarter ended September 30, 2000. The company
will release earnings before the market opens on Wednesday, November 8, 2000.
John R. Plachetka, Pharm.D., POZEN's president and chief executive officer,
and Matthew Czajkowski, chief financial officer, will host the conference call
the same day at 11:00 a.m. Eastern Standard Time.
The conference call will be simulcast live on the Internet, and can be
accessed by logging on to www.vcall.com or www.streetevents.com . A replay
will be available at these sights, as well as on the Investor Relations
section of the company's website, www.pozen.com , for seven days.
North Carolina-based POZEN Inc. is a pharmaceutical development company
committed to building a portfolio of products with significant commercial
potential in select therapeutic areas. The company's initial focus is
migraine, where it has built a portfolio of four product candidates through a
combination of innovation and in-licensing. The company's common stock is
traded on The Nasdaq Stock Market under the symbol "POZN."
POZEN is on the Internet at www.pozen.com .
Chief Financial Officer, of POZEN
Kathy Brunson of FRB Weber Shandwick